Annual CFF
$35.58 M
+$34.62 M+3613.67%
31 December 2023
Summary:
PMV Pharmaceuticals annual cash flow from financing activities is currently $35.58 million, with the most recent change of +$34.62 million (+3613.67%) on 31 December 2023. During the last 3 years, it has fallen by -$257.39 million (-87.86%). PMVP annual CFF is now -87.86% below its all-time high of $292.97 million, reached on 31 December 2020.PMVP Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$0.00
-$141.00 K-100.00%
30 September 2024
Summary:
PMV Pharmaceuticals quarterly cash flow from financing activities is currently $0.00, with the most recent change of -$141.00 thousand (-100.00%) on 30 September 2024. Over the past year, it has dropped by -$33.15 million (-100.00%). PMVP quarterly CFF is now -100.00% below its all-time high of $294.45 million, reached on 30 September 2020.PMVP Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$429.00 K
-$33.15 M-98.72%
30 September 2024
Summary:
PMV Pharmaceuticals TTM cash flow from financing activities is currently $429.00 thousand, with the most recent change of -$33.15 million (-98.72%) on 30 September 2024. Over the past year, it has dropped by -$35.41 million (-98.80%). PMVP TTM CFF is now -99.85% below its all-time high of $294.51 million, reached on 30 June 2021.PMVP TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMVP Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3613.7% | -100.0% | -98.8% |
| 3 y3 years | -87.9% | -100.0% | +16.6% |
| 5 y5 years | +100.0% | - | - |
PMVP Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -87.9% | +3613.7% | -100.0% | -98.8% | +16.6% | |
| 5 y | 5 years | -87.9% | -100.0% | +100.0% | -99.8% | +446.0% | |
| alltime | all time | -87.9% | -100.0% | +100.0% | -99.8% | +446.0% |
PMV Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(-100.0%) | $429.00 K(-98.7%) |
| June 2024 | - | $141.00 K(>+9900.0%) | $33.58 M(-5.6%) |
| Mar 2024 | - | $0.00(-100.0%) | $35.56 M(-0.0%) |
| Dec 2023 | $35.58 M(+3613.7%) | $288.00 K(-99.1%) | $35.58 M(-0.7%) |
| Sept 2023 | - | $33.15 M(+1455.4%) | $35.84 M(+1228.8%) |
| June 2023 | - | $2.13 M(>+9900.0%) | $2.70 M(+220.3%) |
| Mar 2023 | - | $12.00 K(-97.8%) | $842.00 K(-12.1%) |
| Dec 2022 | $958.00 K | $548.00 K(+9033.3%) | $958.00 K(+35.9%) |
| Sept 2022 | - | $6000.00(-97.8%) | $705.00 K(-30.1%) |
| June 2022 | - | $276.00 K(+115.6%) | $1.01 M(-49.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $128.00 K(-56.6%) | $1.99 M(-1.7%) |
| Dec 2021 | $2.02 M(-99.3%) | $295.00 K(-4.5%) | $2.02 M(+449.5%) |
| Sept 2021 | - | $309.00 K(-75.4%) | $368.00 K(-99.9%) |
| June 2021 | - | $1.26 M(+675.3%) | $294.51 M(+0.5%) |
| Mar 2021 | - | $162.00 K(-111.9%) | $293.13 M(+0.1%) |
| Dec 2020 | $292.97 M(+374.0%) | -$1.36 M(-100.5%) | $292.97 M(-0.5%) |
| Sept 2020 | - | $294.45 M(<-9900.0%) | $294.33 M(<-9900.0%) |
| June 2020 | - | -$124.00 K(<-9900.0%) | -$124.00 K(<-9900.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | $61.80 M(>+9900.0%) | - | - |
| Dec 2018 | $0.00 | - | - |
FAQ
- What is PMV Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals annual CFF year-on-year change?
- What is PMV Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals quarterly CFF year-on-year change?
- What is PMV Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals TTM CFF year-on-year change?
What is PMV Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of PMVP is $35.58 M
What is the all time high annual CFF for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high annual cash flow from financing activities is $292.97 M
What is PMV Pharmaceuticals annual CFF year-on-year change?
Over the past year, PMVP annual cash flow from financing activities has changed by +$34.62 M (+3613.67%)
What is PMV Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of PMVP is $0.00
What is the all time high quarterly CFF for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high quarterly cash flow from financing activities is $294.45 M
What is PMV Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, PMVP quarterly cash flow from financing activities has changed by -$33.15 M (-100.00%)
What is PMV Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of PMVP is $429.00 K
What is the all time high TTM CFF for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high TTM cash flow from financing activities is $294.51 M
What is PMV Pharmaceuticals TTM CFF year-on-year change?
Over the past year, PMVP TTM cash flow from financing activities has changed by -$35.41 M (-98.80%)